Lung Neoplasms - Blood
Research News and Information

Sunday, November 22, 2009

Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.

29 Sep 2009 BACKGROUND AND OBJECTIVES: To further improve the screening, diagnosis and therapy of patients with non-small cell lung cancer (NSCLC) additional diagnostic tools are desperately warranted. Aim of this study was to investigate the potential of the ... Read more...

Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.

29 Sep 2009 Urokinase plasminogen activator (uPA) cleaves its three-domain cell surface receptor, uPAR, liberating domain I [uPAR(I)] and leaving the cleaved uPAR(II-III) on the cell surface. Both intact and cleaved uPAR can be shed from the cell surface. ... Read more...

Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004.

30 Aug 2009 BACKGROUND: The Japan-Multinational Trial Organization (JMTO) lung cancer (LC) 0003 was a prospective randomized phase III trial investigating advanced non-small cell lung cancer comparing paclitaxel (P) plus carboplatin (C) versus vinorelbine (V), ... Read more...

Latest indexed articles for 'Lung Neoplasms - Blood'

These are the very latest articles for this heading:

• Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. 29 Sep 2009
• Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer. 29 Sep 2009
• Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004. 30 Aug 2009
• [Assessment of total bilirubin or SN-38/SN-38G ratio as a predictor of severe irinotecan toxicity] 30 Aug 2009
• Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type. 30 Aug 2009
• Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer. 13 Aug 2009
• Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy. 30 Jul 2009
• Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention. 26 Jul 2009
• Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. 21 Jul 2009
• Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. 21 Jul 2009
• DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer. 29 Jun 2009
• VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel. 29 Jun 2009
• Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. 28 Jun 2009
• CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. 27 Jun 2009
• IGF-I and IGFBP-3 and the risk of lung cancer: a meta-analysis based on nested case-control studies. 22 Jun 2009
• Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer. 10 Jun 2009
• Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology. 7 Jun 2009
• [Treatment and outcome of 14 children with hepatoblastoma] 30 May 2009
• Using the differential from complete blood counts as a biomarker of fatigue in advanced non-small-cell lung cancer: an exploratory analysis. 30 May 2009
• Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. 30 May 2009

See a longer list of these articles.

Technical information about 'Lung Neoplasms'

Definition: Tumors or cancer of the LUNG.

Descriptor UI: D008175

Alternative terms: Lung Neoplasms; Neoplasms, Lung; Lung Neoplasm; Neoplasm, Lung; Neoplasms, Pulmonary; Neoplasm, Pulmonary; Pulmonary Neoplasm; Pulmonary Neoplasms; Lung Cancer; Cancer, Lung; Cancers, Lung; Lung Cancers; Pulmonary Cancer; Cancer, Pulmonary; Cancers, Pulmonary; Pulmonary Cancers; Cancer of the Lung; Cancer of Lung;

Related Mesh Headings: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.894.797.520; C08.381.540; C08.785.520;

Technical Notes: coord IM with histol type of neopl (IM)